0 Uncategorized - September 3, 2019NextCure to Present at Morgan Stanley 17th Annual Global Healthcare ConferenceRead More
0 Uncategorized - September 3, 2019Clearside Biomedical to Present at the Janney Montgomery Scott Healthcare ConferenceRead More
0 Uncategorized - September 3, 2019Crinetics Pharmaceuticals to Present at H.C. Wainwright Global Investment ConferenceRead More
0 Uncategorized - September 3, 2019Silvercorp Reports Increased Reserves and Resources at the GC MineRead More
0 Uncategorized - September 3, 2019HealthEquity Reports Second Quarter Ended July 31, 2019 Financial ResultsRead More
0 Uncategorized - September 3, 2019Ferroglobe Completes the Sale of Spanish Hydro Facilities and One Ferroalloys Plant to TPG Sixth Street PartnersRead More
0 Uncategorized - September 3, 2019Fulcrum Therapeutics to Present at the Morgan Stanley 17th Annual Global Healthcare ConferenceRead More
0 Uncategorized - September 3, 2019Turning Point Therapeutics Announces Updated Interim Clinical Data of Repotrectinib and Preclinical Data for TPX-0046, a Novel RET/SRC InhibitorRead More
